Beta Bionics
BBNX
Beta Bionics (BBNX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.53
- EPS estimate
- −$0.58
- EPS surprise
- +8.78%
- Revenue surprise
- +1.75%
- Revenue
- $32.0M
- Revenue estimate
- $31.5M
- Reported
- Jul 29, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | −$0.58 | −$0.53 | +8.78% | $32.0M | SEC |
| Q1 2026 | Apr 21, 2026 | −$0.50 | −$0.49 | +2.53% | $27.6M | SEC |
| Q4 2025 | Feb 17, 2026 | −$0.40 | −$0.30 | +25.60% | $32.1M | SEC |
| Q3 2025 | Oct 28, 2025 | −$0.42 | −$0.33 | +21.99% | $27.3M | SEC |
| Q2 2025 | Jul 29, 2025 | −$0.46 | −$0.39 | +15.01% | $23.2M | SEC |
| Q1 2025 | May 6, 2025 | −$0.48 | −$0.93 | −95.50% | $17.6M | SEC |
| Q4 2024 | Mar 25, 2025 | −$0.90 | −$2.72 | −202.22% | $20.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Beta Bionics (BBNX) last report earnings?
Beta Bionics last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did BBNX beat earnings estimates?
Yes. Beta Bionics reported EPS of −$0.53 for Q2 2026 against a −$0.58 estimate — a 8.78% beat.
How much revenue did BBNX report last quarter?
Beta Bionics reported $32.0M in revenue for Q2 2026, against a consensus estimate of $31.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.